105.46
price down icon1.61%   -1.73
after-market アフターアワーズ: 106.37 0.91 +0.86%
loading
前日終値:
$107.19
開ける:
$107.04
24時間の取引高:
81.59M
Relative Volume:
7.72
時価総額:
$183.26B
収益:
$44.33B
当期純損益:
$6.50B
株価収益率:
28.37
EPS:
3.717
ネットキャッシュフロー:
$7.40B
1週間 パフォーマンス:
-2.38%
1か月 パフォーマンス:
-6.02%
6か月 パフォーマンス:
-22.48%
1年 パフォーマンス:
-16.82%
1日の値動き範囲:
Value
$105.40
$107.79
1週間の範囲:
Value
$105.40
$111.86
52週間の値動き範囲:
Value
$105.27
$139.06

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1110)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
115,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-04-15
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABT icon
ABT
Abbott Laboratories
105.46 183.26B 44.33B 6.50B 7.40B 3.717
SYK icon
SYK
Stryker Corp
335.67 128.46B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
86.16 110.62B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
69.48 103.10B 20.08B 2.89B 3.66B 1.9391
EW icon
EW
Edwards Lifesciences Corp
82.50 47.92B 6.07B 1.06B 1.34B 1.8063

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Mar 21, 2026

Is Abbott Laboratories (ABT) A Good Stock To Buy Now? - Insider Monkey

Mar 21, 2026
pulisher
Mar 21, 2026

St. Louis Financial Planners Asset Management LLC Purchases New Position in Abbott Laboratories $ABT - MarketBeat

Mar 21, 2026
pulisher
Mar 21, 2026

Abbott Labs’ $23 billion deal to acquire Madison’s Exact Sciences set to close Monday - Wisconsin State Journal

Mar 21, 2026
pulisher
Mar 21, 2026

Abbott Laboratories $ABT Shares Purchased by Covea Finance - MarketBeat

Mar 21, 2026
pulisher
Mar 21, 2026

Abbott Laboratories Finalizes Major Acquisition in Cancer Diagnostics - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 21, 2026

Is Abbott Laboratories (ABT) Share Price Weakness Creating A Long Term Opportunity? - simplywall.st

Mar 21, 2026
pulisher
Mar 20, 2026

Abbott Laboratories to close on Exact Sciences purchase - Channel 3000

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott (NYSE:ABT) Expands Diagnostics With Exact Sciences Amid S&P 500 Futures - Kalkine Media

Mar 20, 2026
pulisher
Mar 20, 2026

Exact Sciences and Abbott receive all approvals for planned merger By Investing.com - Investing.com India

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott Laboratories’ CGM Growth Story Looks Obvious—But the NEXT Leg Is Even Bigger! - Smartkarma

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott Laboratories stock underperforms Friday when compared to competitors - MarketWatch

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott Laboratories to close $21B Exact Sciences deal Monday - Modern Healthcare

Mar 20, 2026
pulisher
Mar 20, 2026

When Abbott Labs expects to close on $23B takeover of Exact Sciences - The Business Journals

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott expects to close on acquisition of Madison’s Exact Sciences on Monday - WPR

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott closing Exact Sciences acquisition next week - Channel 3000

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott, Boston Scientific Oppose Spinal Cord Stimulator Lawsuit MDL - AboutLawsuits.com

Mar 20, 2026
pulisher
Mar 20, 2026

Exact Sciences Corp Announces Merger Agreement with Abbott Laboratories – SEC 8-K Filing March 2026 - Minichart

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott to close $21B Exact Sciences acquisition Monday - MedTech Dive

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott (ABT) Finalizes Exact Sciences Acquisition to Boost Cance - GuruFocus

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott to close Exact Sciences acquisition on March 23 - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

Exact Sciences and Abbott receive all approvals for planned merger - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

Exact Sciences Nears Completion of Abbott Acquisition Deal - TipRanks

Mar 20, 2026
pulisher
Mar 20, 2026

Abbott acquisition of Exact Sciences set to close on March 23, 2026 - Abbott MediaRoom

Mar 20, 2026
pulisher
Mar 20, 2026

Cancer test maker Exact Sciences is set to join Abbott March 23 - Stock Titan

Mar 20, 2026
pulisher
Mar 20, 2026

Paradiem LLC Sells 55,579 Shares of Abbott Laboratories $ABT - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

Park National Corp OH Sells 10,527 Shares of Abbott Laboratories $ABT - MarketBeat

Mar 20, 2026
pulisher
Mar 19, 2026

Abbott Acquisition Of Exact Sciences Refocuses Growth On Cancer Diagnostics - simplywall.st

Mar 19, 2026
pulisher
Mar 19, 2026

Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences AcquisitionNews and Statistics - IndexBox

Mar 19, 2026
pulisher
Mar 19, 2026

1 magnificent dividend stock down 22% that's a screaming buy right now - MSN

Mar 19, 2026
pulisher
Mar 19, 2026

1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now - The Motley Fool

Mar 19, 2026
pulisher
Mar 19, 2026

1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now - The Motley Fool

Mar 19, 2026
pulisher
Mar 19, 2026

CIBC Private Wealth Group LLC Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat

Mar 19, 2026
pulisher
Mar 19, 2026

AIA Group Ltd Raises Position in Abbott Laboratories $ABT - MarketBeat

Mar 19, 2026
pulisher
Mar 18, 2026

Abbott Laboratories (ABT) likely to benefit from nutrition segment recovery - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Abbott Investors Ink $40M Deal Over Infant Formula Crisis - Law360

Mar 18, 2026
pulisher
Mar 18, 2026

Futures Contracts for Abbott Laboratories Futures - TradingView

Mar 18, 2026
pulisher
Mar 18, 2026

Selling pressure pushes Abbott Laboratories stock lower in today's trading - Traders Union

Mar 18, 2026
pulisher
Mar 18, 2026

Abbott Labs Leaders, Shareholders Settle Infant Formula Suit (2) - Bloomberg Law News

Mar 18, 2026
pulisher
Mar 18, 2026

Is Trending Stock Abbott Laboratories (ABT) a Buy Now? - Yahoo Finance

Mar 18, 2026
pulisher
Mar 18, 2026

Abbott’s $21 Billion Exact Sciences Acquisition Supports a $179 Price Target - TIKR.com

Mar 18, 2026
pulisher
Mar 18, 2026

Wilmington Savings Fund Society FSB Sells 25,557 Shares of Abbott Laboratories $ABT - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Danske Bank A S Takes $116.41 Million Position in Abbott Laboratories $ABT - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Coldstream Capital Management Inc. Increases Holdings in Abbott Laboratories $ABT - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Will New Diabetes and Cardio Data Shift Abbott Laboratories' (ABT) Chronic-Disease Innovation Narrative - simplywall.st

Mar 18, 2026
pulisher
Mar 17, 2026

Abbott Laboratories Stock (ISIN: US0028241000) Hits Multi-Month Lows Amid Pullback: Buy the Dip Oppo - AD HOC NEWS

Mar 17, 2026
pulisher
Mar 17, 2026

Abbott Laboratories $ABT Shares Purchased by Mariner LLC - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Mairs & Power Inc. Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Abbott Laboratories Stock (ISIN: US0028241000) Shows Resilience Amid Healthcare Sector Headwinds, Tr - AD HOC NEWS

Mar 17, 2026
pulisher
Mar 17, 2026

Mercer Global Advisors Inc. ADV Buys 79,707 Shares of Abbott Laboratories $ABT - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Focus Partners Wealth Has $71 Million Stock Position in Abbott Laboratories $ABT - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Fred Alger Management LLC Has $20.29 Million Position in Abbott Laboratories $ABT - MarketBeat

Mar 17, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
SYK SYK
$335.67
price down icon 1.20%
MDT MDT
$86.16
price down icon 0.82%
BSX BSX
$69.48
price down icon 0.59%
EW EW
$82.50
price up icon 0.05%
$69.65
price down icon 1.04%
大文字化:     |  ボリューム (24 時間):